Congress Materials

PLENVU®

(polyethylene glycol 3350 [140 g], sodium ascorbate [48.11 g], sodium sulfate [9 g], ascorbic acid [7.54 g], sodium chloride [5.2 g], and potassium chloride [2.2 g] for oral solution)

Digestive Disease Week (DDW) 2022—May 21–24, 2022, San Diego, CA + Virtual

NER1006, a 1 liter polyethylene glycol–based bowel preparation, is an independent predictor of adequate and high quality cleansing success in adults undergoing colonoscopy: a pooled analysis of 2 randomized phase 3 trials

Epstein M, et al.

Same-day morning-only dosing of 1L NER1006, a polyethylene glycol bowel preparation, nearly doubles the chance of high-quality cleansing versus standard 2L polyethylene glycol and ascorbate

Epstein M, et al.

Low risk of hypokalemia in adults treated with the 1 liter polyethylene glycol (PEG)–based bowel preparation NER1006: a pooled analysis of 2 randomized phase 3 trials

Cash BD, et al.

Digestive Disease Week (DDW) 2021—May 21–23, 2021, Virtual

NER1006 1 liter polyethylene glycol (PEG)–based bowel preparation safety profile in patients with mild or moderate renal impairment: a pooled analysis of two phase 3 trials  [Encore]

Cash BD, et al.

Advances in Inflammatory Bowel Diseases 2020 Annual Meeting—December 9–12, 2020, Virtual

Efficacy and safety of 1-L NER1006 bowel preparation in patients with inflammatory bowel disease: analysis of 2 phase 3 studies

Poppers D, et al.

American College of Gastroenterology (ACG) Annual Scientific Meeting 2020—October 23–28, 2020, Virtual

One liter polyethylene glycol-based NER1006 is efficacious as a bowel preparation for colonoscopy in patients with or without diabetes mellitus: a pooled analysis of 2 randomized, phase 3 studies

Schoenfeld PS, et al.

NER1006 1 liter polyethylene glycol (PEG)-based bowel preparation safety profile in patients with mild or moderate renal impairment: a pooled analysis of two phase 3 trials

Sharma P, et al.

A pooled safety analysis of the 1 L polyethylene glycol-based bowel preparation NER1006 in adults with vs without diabetes mellitus: a pooled analyses of 2 randomized, phase 3 studies

Cash BD, et al.

Digestive Disease Week (DDW) 2020—May 2–5, 2020, Virtual

Efficacy of 1 L NER1006 bowel preparation for colonoscopy in adults with diabetes: a pooled analysis of two randomized, phase 3 studies

Cash BD, et al.

American College of Gastroenterology (ACG) Annual Scientific Meeting 2019—October 25–30, 2019, San Antonio, TX

1 L NER1006 improves high-quality colon cleansing and mean polyp detection versus oral sulfate solution and 2 L polyethylene glycol plus ascorbate

Epstein M, et al.

Electrolyte shifts of NER1006 bowel preparation for colonoscopy in the elderly are transient and well-tolerated

Epstein MS, et al.

Patient experience with NER1006 as a bowel preparation for colonoscopy: a prospective, multicenter U.S. survey

Cash BD, et al.

American Society of Colon and Rectal Surgeons (ASCRS) 2019 Annual Scientific Meeting—June 1–5, 2019, Cleveland, OH

Improved high-quality colon cleansing with 1 L NER1006 versus 2 L polyethylene glycol + ascorbate or oral sulfate solution [Encore ]

Sher ME, et al.

Digestive Disease Week (DDW) 2019—May 18–21, 2019, San Diego, CA

Plasma electrolyte concentrations after the use of 1L polyethylene glycol bowel preparation NER1006: post hoc analysis of randomised clinical trials

Repici A, et al.

Improved high-quality colon cleansing with 1L NER1006 versus 2L polyethylene glycol + ascorbate or oral sulfate solution

Baumgart DC, et al.

High-quality colon cleansing improves segmental polyp and adenoma detection rates: post hoc analysis of randomised clinical trials using two validated cleansing scales

Epstein M, et al.

Colon cleansing efficacy and safety of 1L NER1006 in patients with mild to moderate renal impairment: post hoc analysis of randomised phase 3 clinical trials

Hassan C, et al.

Digestive Disease Week (DDW) 2018—June 2–5, 2018, Washington, DC

Assessment of patient satisfaction with NER1006 and trisulfate bowel preparations for colonoscopy: a phase 3, randomized, multicenter trial

Epstein M, et al.

Comparative assessment of bowel cleansing of 1 L polyethylene glycol plus ascorbate NER1006 compared with 2 L polyethylene glycol plus ascorbate: a phase 3, randomized, multicenter trial

Epstein M, et al.

World Congress of Gastroenterology (WCG) at ACG 2017—October 13–18, 2017, Orlando, FL

Achieving successful bowel preparation (BBPS score 2-3 per segment) with evening/morning split-dosing regimens of NER1006 versus trisulfate: post hoc analysis of a phase 3 trial

Epstein M, et al.

Achieving successful bowel preparation (BBPS score 2-3 per segment) with evening/morning or morning-only split-dosing regimens of NER1006 versus 2L polyethylene glycol with ascorbate: post hoc analysis of a phase 3 trial

Amlani B, et al.

Bowel preparation quality of NER1006 versus oral trisulfate solution as assessed by colonoscopists at site: a post hoc analysis from a randomized controlled trial

Epstein M, et al.

Novel 1L polyethylene glycol (PEG)-based bowel preparation NER1006 achieves higher quality bowel cleansing with low mandated total fluid volume intake: a post hoc analysis versus standard 2L PEG+ascorbate

Epstein M, et al.

Digestive Disease Week (DDW) 2017—May 6–9, 2017, Chicago, IL

Bowel preparation quality of NER1006 versus standard 2L PEG with ascorbate as assessed by colonoscopists at site: a post hoc analysis from a randomized controlled trial

Manning J, et al.

High cleansing efficacy of NER1006 also in the elderly: post hoc subgroup analysis of randomized phase 3 trials

Jover R, et al.

Digestive Disease Week (DDW) 2016—May 22–24, 2016, San Diego, CA

Efficacy and safety of the novel 1L PEG and ascorbate bowel preparation NER1006 versus standard 2L PEG with ascorbate in overnight or morning split-dosing administration: results from the phase 3 study MORA

Bisschops R, et al.

American College of Gastroenterology (ACG) Annual Scientific Meeting 2014—October 17–22, 2014, Philadelphia, PA

Pharmacodynamic and clinical evaluation of low-volume polyethylene glycol (PEG)-based bowel cleansing solutions (NER1006) using split dosing in healthy and screening colonoscopy subjects

Halphen M, et al.

View product- and therapeutic area—related publications appearing in peer-reviewed journals.

Search

*Required field.

Select a product*

Select

Select a therapeutic area*

Select

Enter keyword(s)